✦ LIBER ✦

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: Results from the DiabEtic Argentina Registry (DEAR)

✍ Scribed by Mieres, Juan; Fernandez-Pereira, Carlos; Risau, Gustavo; Solorzano, Leonardo; Pauletto, Ricardo; Rodriguez-Granillo, Alfredo Matias; Rubilar, Bibiana; Stella, Pieter; Rodriguez, Alfredo E.

Book ID: 119215107
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 826 KB
Volume: 13
Category: Article
ISSN: 1553-8389
DOI: 10.1016/j.carrev.2012.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of glycemic control and hypoglyce

Impact of glycemic control and hypoglycemic agents on the clinical outcome in diabetic patients with percutaneous coronary intervention: from the FU-registry

✍ Amane Ike; Kazuyuki Shirai; Hiroaki Nishikawa; Akira Kawamura; Atsushi Iwata; Ei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Comparison of in-hospital and one-year o

Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)

✍ Warren K Laskey; Faith Selzer; Helen A Vlachos; Janet Johnston; Alice Jacobs; Sp 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Economic outcomes of percutaneous corona

Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial

✍ David J. Cohen; Tara A. Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization for patients with three‐vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long‐term costs with bypass surgery